In vivodelivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vivodelivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 104, Issue 12, Pages 1705-1710
Publisher
Wiley
Online
2013-10-12
DOI
10.1111/cas.12297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vasohibin-2 Expressed in Human Serous Ovarian Adenocarcinoma Accelerates Tumor Growth by Promoting Angiogenesis
- (2012) Y. Takahashi et al. MOLECULAR CANCER RESEARCH
- Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma
- (2012) X Xue et al. ONCOGENE
- Recent advances in systemic treatments for ovarian cancer
- (2012) Susana Banerjee et al. CANCER IMAGING
- Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy
- (2011) Yasufumi Sato CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?
- (2011) Joyce Liu et al. Current Oncology Reports
- Endogenous Angiogenesis Inhibitor Vasohibin1 Exhibits Broad-Spectrum Antilymphangiogenic Activity and Suppresses Lymph Node Metastasis
- (2010) Takahiro Heishi et al. AMERICAN JOURNAL OF PATHOLOGY
- Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas
- (2010) Kousuke Yoshinaga et al. CANCER SCIENCE
- Future Prospect of RNA Interference for Cancer Therapies
- (2010) Eishi Ashihara et al. CURRENT DRUG TARGETS
- Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates Angiogenesis
- (2009) Tomoko Hosaka et al. AMERICAN JOURNAL OF PATHOLOGY
- Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis
- (2009) Hiroshi Kimura et al. BLOOD
- Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast
- (2009) Kentaro Tamaki et al. CANCER SCIENCE
- Bevacizumab in the treatment of breast cancer
- (2009) Angelos K. Koutras et al. CANCER TREATMENT REVIEWS
- Update on novel agents in renal cell carcinoma
- (2009) Ila Tamaskar et al. Expert Review of Anticancer Therapy
- Antiangiogenic therapies for high-grade glioma
- (2009) Andrew D. Norden et al. Nature Reviews Neurology
- Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer
- (2008) Kousuke Yoshinaga et al. CANCER SCIENCE
- Vasohibin-1 in human breast carcinoma: A potential negative feedback regulator of angiogenesis
- (2008) Kentaro Tamaki et al. CANCER SCIENCE
- Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
- (2008) E. Kawata et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started